PGS Sample Set (PSS): PSS009506

Phenotype eGFR<60 mL/min/1.73m2 used to define CKD (stage 3 or greater)
Sample Ancestry African unspecified

Sample Numbers

Total number
14,544 individuals
Detailed numbers
4,268 cases (29.35%)
10,276 controls
0.61% Male samples
Age of Study Participants Mean : 61.0 years
Number of Cohort(s) 7
Sample distribution
Sample gender distribution

Cohort(s)

Cohort Short Name Cohort Full Name Previous/other/additional names (e.g. sub-cohorts)
BioMe BioMe® BioBank Program (Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai) BioMe Biobank (BMBB), MT. SINAI BioMe Biobank Platform (IMP), Charles R Bronfman Institute for Personalized Medicine - IPM / BioBank Genome Wide Association Study of Cardiovascular, Renal and Metabolic Phenotypes (IPM), Charles R Bronfman Institute for Personalized Medicine - IPM / BioBank Genome Wide Association Study of Cardiovascular, Renal and Metabolic Phenotypes I (IPM I), Charles R Bronfman Institute for Personalized Medicine - IPM / BioBank Genome Wide Association Study of Cardiovascular, Renal and Metabolic Phenotypes II (IPM II), IPM_EA_Affy, IPM_EA_Illu, Mount Sinai BioMe BioBank (Mount Sinai)
eMERGE Medical Records and Genomics study
GenHAT Genetics of Hypertension Associated Treatment
HYPERGEN Hypertension Genetic Epidemiology Network
REGARDS Reasons for Geographic and Racial Differences in Stroke
UKB UK Biobank
WPC Warfarin Pharmacogenomics Cohort